In ASX News, Exopharm

Exopharm has been granted a patent for its LEAP technology by Russia’s Patent
Office. The patent underpins a core Exopharm technology that enables the large-scale
purification of exosome medicines.
LEAP patent applications continue to progress through national phases in twelve
jurisdictions.

Recommended Posts